当前位置:首页 - 行情中心 - 迈得医疗(688310) - 财务分析 - 现金流量表

迈得医疗

(688310)

  

流通市值:28.58亿  总市值:28.58亿
流通股本:1.64亿   总股本:1.64亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金98,535,022.74470,462,757.42366,297,764.84250,366,547.28
  收到的税费返还3,316,661.9219,976,656.114,314,122.9110,222,816.45
  收到其他与经营活动有关的现金9,142,653.0226,016,160.1423,844,143.1320,498,580.05
  经营活动现金流入小计110,994,337.68516,455,573.66404,456,030.88281,087,943.78
  购买商品、接受劳务支付的现金58,934,422.52159,098,614.66125,130,794.9459,887,408.13
  支付给职工以及为职工支付的现金43,470,990.45109,516,630.0883,859,066.1355,940,851.39
  支付的各项税费21,212,325.1535,144,539.3425,261,217.6818,544,976.1
  支付其他与经营活动有关的现金14,618,052.9661,478,310.5243,958,802.5833,433,050.41
  经营活动现金流出小计138,235,791.08365,238,094.6278,209,881.33167,806,286.03
  经营活动产生的现金流量净额-27,241,453.4151,217,479.06126,246,149.55113,281,657.75
二、投资活动产生的现金流量:
  收回投资收到的现金50,007,698.9940,953,301.1707,961,000208,961,000
  取得投资收益收到的现金261,966.454,213,313.532,884,612.52,039,338.65
  处置固定资产、无形资产和其他长期资产收回的现金净额19,816.2145,0001,617,334.81126,000
  投资活动现金流入小计50,289,481.55945,311,614.63712,462,947.31211,126,338.65
  购建固定资产、无形资产和其他长期资产支付的现金22,407,449.6553,954,150.3153,054,975.2328,389,918.37
  投资支付的现金70,000,000942,000,000814,818,374.97259,000,000
  投资活动现金流出小计92,407,449.65995,954,150.31867,873,350.2287,389,918.37
  投资活动产生的现金流量净额-42,117,968.1-50,642,535.68-155,410,402.89-76,263,579.72
三、筹资活动产生的现金流量:
  吸收投资收到的现金-16,927,40016,927,4001,400,000
  其中:子公司吸收少数股东投资收到的现金-16,927,40016,927,4001,400,000
  取得借款收到的现金2,981,40021,017,879.421,048,258.5917,484,626.48
  筹资活动现金流入小计2,981,40037,945,279.437,975,658.5918,884,626.48
  偿还债务支付的现金2,438,083.2770,000--
  分配股利、利润或偿付利息支付的现金15,617,112.681,267,621.18918,491.98549,875.73
  支付其他与筹资活动有关的现金25,699,648.9518,160,144.1815,313,123.5917,063,239.53
  筹资活动现金流出小计43,754,844.919,497,765.3616,231,615.5717,613,115.26
  筹资活动产生的现金流量净额-40,773,444.918,447,514.0421,744,043.021,271,511.22
四、汇率变动对现金及现金等价物的影响-1,041,184.28-800,572.14-257,510.787,323.13
五、现金及现金等价物净增加额-111,174,050.68118,221,885.28-7,677,721.0238,376,912.38
  加:期初现金及现金等价物余额227,071,720.61109,005,903.17109,005,903.17109,005,903.17
  期末现金及现金等价物余额115,897,669.93227,227,788.45101,328,182.15147,382,815.55
补充资料:
  净利润-44,569,148.16--1,819,426.24
  资产减值准备-2,038,568.27-667,413.23
  固定资产和投资性房地产折旧-37,576,776.79-15,706,958.84
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-37,576,776.79-15,706,958.84
  无形资产摊销-1,868,979.01-920,427.02
  长期待摊费用摊销-673,159.41-111,438.3
  处置固定资产、无形资产和其他长期资产的损失-51,293.81-98,292.8
  固定资产报废损失-60,506.51--
  公允价值变动损失--3,804,858--1,270,153.83
  财务费用-1,109,088.1--117,373.25
  投资损失--671,236.27--174,638.08
  递延所得税-2,201,647.57-2,591,022.1
  其中:递延所得税资产减少-2,184,748.81-2,591,022.1
    递延所得税负债增加-16,898.76--
  存货的减少--20,600,823.17--24,168,527.24
  经营性应收项目的减少-55,119,745.1--23,081,373.2
  经营性应付项目的增加-35,668,393.28-144,272,232.79
  其他-1,087,657.07--
  现金的期末余额-227,227,788.45-147,382,815.55
  减:现金的期初余额-109,005,903.17-109,005,903.17
  现金及现金等价物的净增加额-118,221,885.28-38,376,912.38
公告日期2026-04-292026-04-292025-10-282025-08-28
审计意见(境内)标准无保留意见
TOP↑